Skip to content

Medical-device intelligence

NQX: System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

FDA product code NQX: System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NQX
FDA device name
System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

FDA definition

A nucleic acid amplification assay system (including probes, other reagents, and instrumentation) is an aid in the identification of MRSA colonization status for the prevention and control of MRSA infections in healthcare settings.
Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

24 clearance records and 20 recall records in the covered releases, across 14 source company names and 1 product codes. Dated history runs from Mar 18, 2004 to Aug 6, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

44 matching records
Device / recordCompany in FDA recordSourceSource date
Xpert SA Nasal Complete Catalog Number: GXSACOMP-10 UDI-DI code: 07332940000158 Xpert SA Nasal Complete kit; 10 test kit: A collection of reagen…Z-0414-2026 · NQXCepheidRecallOct 30, 2025FDA classification date
Xpert MRSA/SA SSTIK243625 · NQXCepheid®510(k)Dec 18, 2024FDA decision date
Xpert® SA Nasal CompleteK243070 · NQXCepheid®510(k)Oct 25, 2024FDA decision date
ARIES MRSA AssayK191742 · NQXLuminex Corporation510(k)Sep 25, 2019FDA decision date
Kit BD Max MRSA; Catalog # 442953Z-2328-2019 · NQXBecton Dickinson & Co.RecallAug 22, 2019FDA record creation date
Kit BD Max StaphSR; Catalog # 443418Z-2332-2019 · NQXBecton Dickinson & Co.RecallAug 22, 2019FDA record creation date
Kit BD Max StaphSR; Catalog # 443419Z-2333-2019 · NQXBecton Dickinson & Co.RecallAug 22, 2019FDA record creation date
Kit BD Max MRSA XT; Catalog # 443461Z-2334-2019 · NQXBecton Dickinson & Co.RecallAug 22, 2019FDA record creation date
Xpert MRSA/SA Blood Culture, GeneXpert Dx System, GeneXpert Infinity-48s System, GeneXpert Infinity-80 SystemK190771 · NQXCepheid510(k)Apr 25, 2019FDA decision date
Nucleic Acid test intended for screening for MRSA/SA. Each kit has 20 tubes. in vitro diagnostic.Z-1195-2018 · NQXRoche Molecular Systems, Inc.RecallMar 26, 2018FDA record creation date
Xpert MRSA NxGK162444 · NQXCepheid510(k)Nov 23, 2016FDA decision date
Xpert MRSA Catalog GXMRSA-120, Rev. AJ Microbiology: The Cepheid Xpert MRSA assay performed in the GeneXpert Dx System (Xpert MRSA) is a qualit…Z-2548-2016 · NQXCepheidRecallAug 16, 2016FDA record creation date
cobas MRSA/SA TestK142721 · NQXRoche Molecular Systems, Inc.510(k)Dec 17, 2014FDA decision date
The BD MAX MRSA Assay, catalogue #442953. An automated qualitative in vitro diagnostic test for the direct detection of Methicillin-resistant …Z-2618-2014 · NQXBecton Dickinson & Co.RecallSep 10, 2014FDA classification date
BD MAX MRSA XT, BD MAX INSTRUMENTK133605 · NQXGeneohm Sciences Canada, Inc.510(k)Dec 20, 2013FDA decision date
BD MAX STAPHSR ASSAY, INSTRUMENTK132822 · NQXGeneohm Sciences Canada, Inc. (Bd Diagnostics)510(k)Nov 26, 2013FDA decision date
MRSA/SA ELITE MGB, ELITE MGB SOFTWAREK132468 · NQXElitechgroup Epoch Biosciences510(k)Oct 17, 2013FDA decision date
XPERT MRSA/SA BLOOD CULTURE ASSAY; GENEXPERT DX SYSTEMS (GX-I, GX-II, GX-IV, GX-XVI); GENEXPERT INFINITY-48 SYSTEM; GENEK130894 · NQXCepheid510(k)Jun 20, 2013FDA decision date
BD GeneOhm MRSA ACP Assay, Catalog #441639, box 200 tests labeled in part***GeneOhm Sciences Canada, Inc. 2555 Boul, du Parc-Technologique, Quebe…Z-2317-2012 · NQXBecton Dickinson & Co.RecallSep 6, 2012FDA classification date
BD MAX MRSA ASSAY, BD MAX INSTRUMENTK120138 · NQXBd Diagnostics (Geneohm Sciences Canada, Inc)510(k)Jul 5, 2012FDA decision date
MRSA/SA ELITE MGBK112937 · NQXElitech510(k)Jun 1, 2012FDA decision date
Cepheid brand Xpert MRSA/SA-BC US-IVD, an In-vitro diagnostic test kit, Catalog Numbers: GXMRSA/SA-BC-10, Lots Affected: 2803 and 3001;Z-0453-2012 · NQXCepheidRecallJan 11, 2012FDA classification date
VERIGENE STAPHYLOCOCCUS BLOOD CULTURE NUCLEIC ACID TEST (BC-S)K112424 · NQXNanosphere, Inc.510(k)Dec 16, 2011FDA decision date
BD MAX DNA Extraction Kit DNA-1 (Urine/Plasma) Catalog Number 437501. Kit contains 24/2D barcode sample preparation reagent tubes ***For use with…Z-3216-2011 · NQXBecton Dickinson & Co.RecallSep 16, 2011FDA classification date
BD MAX DNA Extraction Kit DNA-2 (Whole Blood) Catalog Number 437502. Kit contains 24/2D barcode sample preparation reagent tubes *** For use wit…Z-3217-2011 · NQXBecton Dickinson & Co.RecallSep 16, 2011FDA classification date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗